We are live on ! Find out more
NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

53 hedge funds and large institutions have $50.6M invested in NeuBase Therapeutics, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more call options, than puts

Call options by funds: $868K | Put options by funds: $374K

75% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 4

17% more capital invested

Capital invested by funds: $43.1M → $50.6M (+$7.51M)

2% more funds holding

Funds holding: 52 → 53 (+1)

0% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 17

Holders
53
Holders Change
+1
Holders Change %
+1.92%
% of All Funds
1.41%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
17
Reduced
17
Closed
4
Calls
$868K
Puts
$374K
Net Calls
+$494K
Net Calls Change
-$415K

Top Buyers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
+$886K
2
AllianceBernstein
AllianceBernstein
Tennessee
+$865K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$334K
4
LOAMU
Lombard Odier Asset Management (USA)
New York
+$291K
5
BIC
Beach Investment Counsel
Pennsylvania
+$270K

Top Sellers

Rank Fund Capital Flow
1
VAM
Visium Asset Management
New York
-$1.15M
2
Millennium Management
Millennium Management
New York
-$438K
3
Goldman Sachs
Goldman Sachs
New York
-$386K
4
SM
Sabby Management
Florida
-$224K
5
Citadel Advisors
Citadel Advisors
Florida
-$68K
Name Holding Trade Value Shares
Change 		Change in
Stake
UBS Group
26
UBS Group
Switzerland
$290K +$267K +87 New
Charles Schwab
27
Charles Schwab
California
$258K – – –
TA
28
Teachers Advisors
New York
$242K – – –
FNBT
29
FineMark National Bank & Trust
Florida
$188K +$141K +46 +460%
Group One Trading
30
Group One Trading
Illinois
$184K -$9.2K -3 -5%
PPCM
31
Pillar Pacific Capital Management
California
$148K -$3.07K -1 -2%
First Manhattan
32
First Manhattan
New York
$145K +$120K +39 +780%
RhumbLine Advisers
33
RhumbLine Advisers
Massachusetts
$142K +$6.13K +2 +5%
NFA
34
Nationwide Fund Advisors
Ohio
$134K – – –
CCB
35
Cutter & Co Brokerage
Missouri
$125K +$117K +38 New
AIG
36
American International Group
New York
$110K -$3.07K -1 -3%
AQR Capital Management
37
AQR Capital Management
Connecticut
$109K – – –
T. Rowe Price Associates
38
T. Rowe Price Associates
Maryland
$108K -$9.2K -3 -8%
BA
39
BlackRock Advisors
Delaware
$66K -$3.07K -1 -5%
PA
40
Perceptive Advisors
New York
$50K +$46K +15 New
NES
41
New England Securities
New York
$33K – – –
Citigroup
42
Citigroup
New York
$31K +$21.5K +7 +350%
Morgan Stanley
43
Morgan Stanley
New York
$30K -$9.2K -3 -25%
SGAM
44
Smith Group Asset Management
Texas
$28K – – –
Wells Fargo
45
Wells Fargo
California
$23K – – –
HCC
46
Hirtle Callaghan & Co
Pennsylvania
$18K – – –
TRCT
47
Tower Research Capital (TRC)
New York
$7K -$55.2K -18 -90%
Bank of America
48
Bank of America
North Carolina
$4K -$67.4K -22 -96%
HF
49
Hoxton Financial
West Virginia
$3K -$33.7K -11 -92%
LS
50
Lupo Securities
Illinois
$1.67K +$3.07K +1 New
1
2
3

NBSE Hedge Fund Activity: Q4 2014 in Review

53 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in NeuBase Therapeutics, Inc. Common Stock (NBSE) for Q4 2014, worth a combined $50.6M — up 17% from $43.1M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new NBSE positions and 4 closed out — a net gain of 3 holders — while 17 added to existing stakes and 17 trimmed.

The largest buyer was BlackRock Fund Advisors, adding an estimated $886K. The largest seller was Visium Asset Management, cutting an estimated $1.15M.

  • 53 institutional investors held NeuBase Therapeutics, Inc. Common Stock (NBSE) as of Q4 2014, up from 52 in Q3 2014.
  • Funds reported $50.6M of NeuBase Therapeutics, Inc. Common Stock stock for Q4 2014, up 17% quarter-over-quarter.
  • 7 funds opened new NeuBase Therapeutics, Inc. Common Stock positions in Q4 2014 and 4 closed out, a net change of +3 holders.
  • The largest NeuBase Therapeutics, Inc. Common Stock buyer in Q4 2014 was BlackRock Fund Advisors, an estimated $886K added.
  • The largest NeuBase Therapeutics, Inc. Common Stock seller in Q4 2014 was Visium Asset Management, an estimated $1.15M sold.

Based on aggregated 13F filings for Q4 2014.